Runguo Wu

Dec 5, 2024 | journalslibrary.nihr.ac.uk | Borislava Mihaylova |Runguo Wu |Junwen Zhou |Claire Williams

Members of the project oversight group: Colin Baigent, Alison Gater, Borislava Mihaylova, Stephen Morris, Paul Roderick (chairperson), Natalie Rowland, Peter Sever and Liam Smeeth. We thank the external members of our project oversight group for their guidance and support throughout the project development.

Oct 10, 2024 | heart.bmj.com | Borislava Mihaylova |Runguo Wu |Junwen Zhou |Claire Williams

Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Sep 24, 2024 | heart.bmj.com | Borislava Mihaylova |Runguo Wu |Junwen Zhou |Claire Williams

Healthcare delivery, economics and global health Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Sep 10, 2024 | heart.bmj.com | Borislava Mihaylova |Runguo Wu |Junwen Zhou |Claire Williams

Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Feb 29, 2024 | bjgp.org | Runguo Wu |Claire Williams |Junwen Zhou |Iryna Schlackow

cardiovascular disease individual patient characteristics inequality Markov microsimulation model socioeconomic status quality-adjusted life years Introduction Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality globally.1 In the UK, despite declines in age-standardised CVD mortality and morbidity over the last few decades, CVD remains a significant burden for the health system.2 Regional and socioeconomic inequalities persist, with slower improvements in the most...